{"assetProfile": {"address1": "An der Goldgrube 12", "city": "Mainz", "zip": "55131", "country": "Germany", "phone": "49 6131 9084", "fax": "49 6131 9084", "website": "https://www.biontech.de", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.", "fullTimeEmployees": 6772, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ugur  Sahin M.D.", "age": 59, "title": "Co-Founder, CEO & Chair of the Management Board", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": {"raw": 1112346, "fmt": "1.11M", "longFmt": "1,112,346"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ozlem  Tureci M.D.", "age": 57, "title": "Co-Founder, Chief Medical Officer & Member of Management Board", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": {"raw": 889877, "fmt": "889.88k", "longFmt": "889,877"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Sierk  Poetting Ph.D.", "age": 51, "title": "MD, COO & Member of Management Board", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": {"raw": 911778, "fmt": "911.78k", "longFmt": "911,778"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. James Timothy Patrick Ryan Ph.D.", "age": 49, "title": "Chief Legal & Business Officer and Member of the Management Board", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": {"raw": 1015520, "fmt": "1.02M", "longFmt": "1,015,520"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Annemarie  Hanekamp", "age": 44, "title": "Chief Commercial Officer & Member of Management Board", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": {"raw": 1990696, "fmt": "1.99M", "longFmt": "1,990,696"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ramon  Zapata-Gomez", "title": "CFO & Member of Management Board", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Lisa  Birringer", "title": "Senior Vice President of Global Financial Reporting & Accounting", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Beate  Berns", "title": "Senior Vice President of Global Human Resources", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Oliver  Henning Ph.D.", "title": "Senior Vice President of Operations", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Sebastian  Kreiter M.D.", "title": "Senior Vice President of Immunotherapy & Preclinical Research", "fiscalYear": 2024, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 3, "boardRisk": 4, "compensationRisk": 8, "shareHolderRightsRisk": 1, "overallRisk": 5, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400}, "calendarEvents": {"maxAge": 1, "earnings": {"earningsDate": [{"raw": 1762176600, "fmt": "2025-11-03"}], "earningsCallDate": [{"raw": 1762174800, "fmt": "2025-11-03"}], "isEarningsDateEstimate": false, "earningsAverage": {"raw": -0.78356, "fmt": "-0.78"}, "earningsLow": {"raw": -3.15, "fmt": "-3.15"}, "earningsHigh": {"raw": 0.6, "fmt": "0.60"}, "revenueAverage": {"raw": 667966520, "fmt": "667.97M", "longFmt": "667,966,520"}, "revenueLow": {"raw": 667966520, "fmt": "667.97M", "longFmt": "667,966,520"}, "revenueHigh": {"raw": 667966520, "fmt": "667.97M", "longFmt": "667,966,520"}}, "exDividendDate": {"raw": 1654128000, "fmt": "2022-06-02"}, "dividendDate": {"raw": 1655424000, "fmt": "2022-06-17"}}, "earningsTrend": {"trend": [{"maxAge": 1, "period": "0q", "endDate": "2025-12-31", "growth": {"raw": -1.7255, "fmt": "-172.55%"}, "earningsEstimate": {"avg": {"raw": -0.78356, "fmt": "-0.78"}, "low": {"raw": -3.15, "fmt": "-3.15"}, "high": {"raw": 0.6, "fmt": "0.6"}, "yearAgoEps": {"raw": 1.08, "fmt": "1.08"}, "numberOfAnalysts": {"raw": 14, "fmt": "14", "longFmt": "14"}, "growth": {"raw": -1.7255, "fmt": "-172.55%"}, "earningsCurrency": "EUR"}, "revenueEstimate": {"avg": {"raw": 667966520, "fmt": "667.97M", "longFmt": "667,966,520"}, "low": {"raw": 667966520, "fmt": "667.97M", "longFmt": "667,966,520"}, "high": {"raw": 667966520, "fmt": "667.97M", "longFmt": "667,966,520"}, "numberOfAnalysts": {"raw": 1, "fmt": "1", "longFmt": "1"}, "yearAgoRevenue": {"raw": 1190000000, "fmt": "1.19B", "longFmt": "1,190,000,000"}, "growth": {"raw": -0.4387, "fmt": "-43.87%"}, "revenueCurrency": "EUR"}, "epsTrend": {"current": {"raw": -0.78356, "fmt": "-0.78"}, "7daysAgo": {"raw": -1.06785, "fmt": "-1.07"}, "30daysAgo": {"raw": -0.96025, "fmt": "-0.96"}, "60daysAgo": {"raw": -0.97405, "fmt": "-0.97"}, "90daysAgo": {"raw": -0.87106, "fmt": "-0.87"}, "epsTrendCurrency": "EUR"}, "epsRevisions": {"upLast7days": {"raw": 0, "fmt": null, "longFmt": "0"}, "upLast30days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast30days": {"raw": 3, "fmt": "3", "longFmt": "3"}, "downLast7Days": {"raw": 3, "fmt": "3", "longFmt": "3"}, "downLast90days": {}, "epsRevisionsCurrency": "EUR"}}, {"maxAge": 1, "period": "+1q", "endDate": "2026-03-31", "growth": {"raw": -0.1344, "fmt": "-13.44%"}, "earningsEstimate": {"avg": {"raw": -1.9625, "fmt": "-1.96"}, "low": {"raw": -2.59, "fmt": "-2.59"}, "high": {"raw": -1.1, "fmt": "-1.1"}, "yearAgoEps": {"raw": -1.73, "fmt": "-1.73"}, "numberOfAnalysts": {"raw": 4, "fmt": "4", "longFmt": "4"}, "growth": {"raw": -0.1344, "fmt": "-13.44%"}, "earningsCurrency": "EUR"}, "revenueEstimate": {"avg": {"raw": 265636500, "fmt": "265.64M", "longFmt": "265,636,500"}, "low": {"raw": 153500000, "fmt": "153.5M", "longFmt": "153,500,000"}, "high": {"raw": 377773000, "fmt": "377.77M", "longFmt": "377,773,000"}, "numberOfAnalysts": {"raw": 2, "fmt": "2", "longFmt": "2"}, "yearAgoRevenue": {"raw": 182800000, "fmt": "182.8M", "longFmt": "182,800,000"}, "growth": {"raw": 0.45319998, "fmt": "45.32%"}, "revenueCurrency": "EUR"}, "epsTrend": {"current": {"raw": -1.9625, "fmt": "-1.96"}, "7daysAgo": {"raw": -1.9625, "fmt": "-1.96"}, "30daysAgo": {"raw": -1.9625, "fmt": "-1.96"}, "60daysAgo": {"raw": -1.9625, "fmt": "-1.96"}, "90daysAgo": {"raw": -2.02, "fmt": "-2.02"}, "epsTrendCurrency": "EUR"}, "epsRevisions": {"upLast7days": {"raw": 0, "fmt": null, "longFmt": "0"}, "upLast30days": {"raw": 2, "fmt": "2", "longFmt": "2"}, "downLast30days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast7Days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast90days": {}, "epsRevisionsCurrency": "EUR"}}, {"maxAge": 1, "period": "0y", "endDate": "2025-12-31", "growth": {"raw": -0.5117, "fmt": "-51.17%"}, "earningsEstimate": {"avg": {"raw": -4.18741, "fmt": "-4.19"}, "low": {"raw": -8.29, "fmt": "-8.29"}, "high": {"raw": 1.59, "fmt": "1.59"}, "yearAgoEps": {"raw": -2.77, "fmt": "-2.77"}, "numberOfAnalysts": {"raw": 19, "fmt": "19", "longFmt": "19"}, "growth": {"raw": -0.5117, "fmt": "-51.17%"}, "earningsCurrency": "EUR"}, "revenueEstimate": {"avg": {"raw": 2725416630, "fmt": "2.73B", "longFmt": "2,725,416,630"}, "low": {"raw": 2630466520, "fmt": "2.63B", "longFmt": "2,630,466,520"}, "high": {"raw": 2807000000, "fmt": "2.81B", "longFmt": "2,807,000,000"}, "numberOfAnalysts": {"raw": 4, "fmt": "4", "longFmt": "4"}, "yearAgoRevenue": {"raw": 2751100000, "fmt": "2.75B", "longFmt": "2,751,100,000"}, "growth": {"raw": -0.0093, "fmt": "-0.93%"}, "revenueCurrency": "EUR"}, "epsTrend": {"current": {"raw": -4.18741, "fmt": "-4.19"}, "7daysAgo": {"raw": -4.04847, "fmt": "-4.05"}, "30daysAgo": {"raw": -4.04553, "fmt": "-4.05"}, "60daysAgo": {"raw": -4.08489, "fmt": "-4.08"}, "90daysAgo": {"raw": -4.03961, "fmt": "-4.04"}, "epsTrendCurrency": "EUR"}, "epsRevisions": {"upLast7days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "upLast30days": {"raw": 2, "fmt": "2", "longFmt": "2"}, "downLast30days": {"raw": 4, "fmt": "4", "longFmt": "4"}, "downLast7Days": {"raw": 3, "fmt": "3", "longFmt": "3"}, "downLast90days": {}, "epsRevisionsCurrency": "EUR"}}, {"maxAge": 1, "period": "+1y", "endDate": "2026-12-31", "growth": {"raw": 0.1731, "fmt": "17.31%"}, "earningsEstimate": {"avg": {"raw": -3.46264, "fmt": "-3.46"}, "low": {"raw": -7.85, "fmt": "-7.85"}, "high": {"raw": 1.05, "fmt": "1.05"}, "yearAgoEps": {"raw": -4.18741, "fmt": "-4.19"}, "numberOfAnalysts": {"raw": 19, "fmt": "19", "longFmt": "19"}, "growth": {"raw": 0.1731, "fmt": "17.31%"}, "earningsCurrency": "EUR"}, "revenueEstimate": {"avg": {"raw": 2498436630, "fmt": "2.5B", "longFmt": "2,498,436,630"}, "low": {"raw": 1583000000, "fmt": "1.58B", "longFmt": "1,583,000,000"}, "high": {"raw": 3317700000, "fmt": "3.32B", "longFmt": "3,317,700,000"}, "numberOfAnalysts": {"raw": 18, "fmt": "18", "longFmt": "18"}, "yearAgoRevenue": {"raw": 2725416630, "fmt": "2.73B", "longFmt": "2,725,416,630"}, "growth": {"raw": -0.0833, "fmt": "-8.33%"}, "revenueCurrency": "EUR"}, "epsTrend": {"current": {"raw": -3.46264, "fmt": "-3.46"}, "7daysAgo": {"raw": -3.59211, "fmt": "-3.59"}, "30daysAgo": {"raw": -3.69456, "fmt": "-3.69"}, "60daysAgo": {"raw": -3.76688, "fmt": "-3.77"}, "90daysAgo": {"raw": -3.88262, "fmt": "-3.88"}, "epsTrendCurrency": "EUR"}, "epsRevisions": {"upLast7days": {"raw": 0, "fmt": null, "longFmt": "0"}, "upLast30days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast30days": {"raw": 5, "fmt": "5", "longFmt": "5"}, "downLast7Days": {"raw": 3, "fmt": "3", "longFmt": "3"}, "downLast90days": {}, "epsRevisionsCurrency": "EUR"}}], "defaultMethodology": "nongaap", "maxAge": 1}, "earningsHistory": {"history": [{"maxAge": 1, "epsActual": {"raw": 1.08, "fmt": "1.08"}, "epsEstimate": {"raw": 0.37386, "fmt": "0.37"}, "epsDifference": {"raw": 0.71, "fmt": "0.71"}, "surprisePercent": {"raw": 1.8888, "fmt": "188.88%"}, "quarter": {"raw": 1735603200, "fmt": "2024-12-31"}, "currency": "EUR", "period": "-4q"}, {"maxAge": 1, "epsActual": {"raw": -1.73, "fmt": "-1.73"}, "epsEstimate": {"raw": -2.34707, "fmt": "-2.35"}, "epsDifference": {"raw": 0.62, "fmt": "0.62"}, "surprisePercent": {"raw": 0.2629, "fmt": "26.29%"}, "quarter": {"raw": 1743379200, "fmt": "2025-03-31"}, "currency": "EUR", "period": "-3q"}, {"maxAge": 1, "epsActual": {"raw": -1.6, "fmt": "-1.6"}, "epsEstimate": {"raw": -1.40552, "fmt": "-1.41"}, "epsDifference": {"raw": -0.19, "fmt": "-0.19"}, "surprisePercent": {"raw": -0.1384, "fmt": "-13.84%"}, "quarter": {"raw": 1751241600, "fmt": "2025-06-30"}, "currency": "EUR", "period": "-2q"}, {"maxAge": 1, "epsActual": {"raw": -0.12, "fmt": "-0.12"}, "epsEstimate": {"raw": 0.09972, "fmt": "0.1"}, "epsDifference": {"raw": -0.22, "fmt": "-0.22"}, "surprisePercent": {"raw": -2.2034, "fmt": "-220.34%"}, "quarter": {"raw": 1759190400, "fmt": "2025-09-30"}, "currency": "EUR", "period": "-1q"}], "defaultMethodology": "nongaap", "maxAge": 86400}, "financialData": {"maxAge": 86400, "currentPrice": {"raw": 103.955, "fmt": "103.96"}, "targetHighPrice": {"raw": 170.72406, "fmt": "170.72"}, "targetLowPrice": {"raw": 98.008514, "fmt": "98.01"}, "targetMeanPrice": {"raw": 133.73189, "fmt": "133.73"}, "targetMedianPrice": {"raw": 134.9977, "fmt": "135.00"}, "recommendationMean": {"raw": 1.66667, "fmt": "1.67"}, "recommendationKey": "buy", "numberOfAnalystOpinions": {"raw": 20, "fmt": "20", "longFmt": "20"}, "totalCash": {"raw": 14527599616, "fmt": "14.53B", "longFmt": "14,527,599,616"}, "totalCashPerShare": {"raw": 60.417, "fmt": "60.42"}, "ebitda": {"raw": -566899968, "fmt": "-566.9M", "longFmt": "-566,899,968"}, "totalDebt": {"raw": 245400000, "fmt": "245.4M", "longFmt": "245,400,000"}, "quickRatio": {"raw": 6.89, "fmt": "6.89"}, "currentRatio": {"raw": 7.123, "fmt": "7.12"}, "totalRevenue": {"raw": 3152499968, "fmt": "3.15B", "longFmt": "3,152,499,968"}, "debtToEquity": {"raw": 1.328, "fmt": "1.33%"}, "revenuePerShare": {"raw": 13.137, "fmt": "13.14"}, "returnOnAssets": {"raw": -0.02585, "fmt": "-2.58%"}, "returnOnEquity": {"raw": -0.03041, "fmt": "-3.04%"}, "grossProfits": {"raw": 2600499968, "fmt": "2.6B", "longFmt": "2,600,499,968"}, "freeCashflow": {"raw": -845324992, "fmt": "-845.32M", "longFmt": "-845,324,992"}, "operatingCashflow": {"raw": -316800000, "fmt": "-316.8M", "longFmt": "-316,800,000"}, "earningsGrowth": {}, "revenueGrowth": {"raw": 0.22, "fmt": "22.00%"}, "grossMargins": {"raw": 0.8249, "fmt": "82.49%"}, "ebitdaMargins": {"raw": -0.17983, "fmt": "-17.98%"}, "operatingMargins": {"raw": -0.03088, "fmt": "-3.09%"}, "profitMargins": {"raw": -0.18132, "fmt": "-18.13%"}, "financialCurrency": "EUR"}}